G. Littlejohn

471 total citations
11 papers, 368 citations indexed

About

G. Littlejohn is a scholar working on Rheumatology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, G. Littlejohn has authored 11 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Pharmacology and 4 papers in Psychiatry and Mental health. Recurrent topics in G. Littlejohn's work include Rheumatoid Arthritis Research and Therapies (5 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Musculoskeletal pain and rehabilitation (4 papers). G. Littlejohn is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Musculoskeletal pain and rehabilitation (4 papers). G. Littlejohn collaborates with scholars based in Australia, Canada and United States. G. Littlejohn's co-authors include Deborah N. D’Souza, Daniel K. Kajdasz, Amy S. Chappell, Morton Scheinberg, Harvey Moldofsky, Kathleen Tymms, Lynden Roberts, Hedley Griffiths, Dave Nicholls and Jane Zochling and has published in prestigious journals such as Nature Reviews Rheumatology, The Medical Journal of Australia and Clinical Journal of Pain.

In The Last Decade

G. Littlejohn

11 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Littlejohn Australia	7	143	142	140	75	52	11	368
R. Alten Germany	6	73 0.5×	60 0.4×	100 0.7×	27 0.4×	28 0.5×	19	259
María Betina Nishishinya Spain	10	127 0.9×	133 0.9×	38 0.3×	81 1.1×	18 0.3×	17	344
Alyssa Wohlfahrt United States	12	148 1.0×	71 0.5×	229 1.6×	96 1.3×	60 1.2×	21	431
Gladstone McDowell United States	7	100 0.7×	29 0.2×	67 0.5×	87 1.2×	7 0.1×	18	446
Dina Dadabhoy United States	6	276 1.9×	211 1.5×	38 0.3×	49 0.7×	2 0.0×	7	511
Daphna Alkalay Israel	8	198 1.4×	184 1.3×	43 0.3×	41 0.5×	2 0.0×	10	434
Remzi Yiğiter Türkiye	10	78 0.5×	27 0.2×	16 0.1×	34 0.5×	8 0.2×	26	299
Paolo Proto Netherlands	8	19 0.1×	102 0.7×	12 0.1×	240 3.2×	48 0.9×	13	408
N. S. BROWN United Kingdom	14	64 0.4×	34 0.2×	48 0.3×	38 0.5×	10 0.2×	23	509
Ehab Youseif Egypt	7	26 0.2×	196 1.4×	30 0.2×	207 2.8×	10 0.2×	8	346

Countries citing papers authored by G. Littlejohn

Since Specialization

Citations

This map shows the geographic impact of G. Littlejohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Littlejohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Littlejohn more than expected).

Fields of papers citing papers by G. Littlejohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Littlejohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Littlejohn. The network helps show where G. Littlejohn may publish in the future.

Co-authorship network of co-authors of G. Littlejohn

This figure shows the co-authorship network connecting the top 25 collaborators of G. Littlejohn. A scholar is included among the top collaborators of G. Littlejohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Littlejohn. G. Littlejohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Littlejohn, G.. (2015). Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome. Nature Reviews Rheumatology. 11(11). 639–648. 133 indexed citations

Littlejohn, G.. (2014). Honing fibromyalgia diagnosis. Nature Reviews Rheumatology. 10(5). 267–269. 8 indexed citations

Tymms, Kathleen & G. Littlejohn. (2014). OPAL: a clinician driven point of care observational data management consortium.. PubMed. 32(5 Suppl 85). S–150. 3 indexed citations

Tymms, Kathleen, Jane Zochling, James A. Scott, et al.. (2013). Barriers to Optimal Disease Control for Rheumatoid Arthritis Patients With Moderate and High Disease Activity. Arthritis Care & Research. 66(2). 190–196. 54 indexed citations

Littlejohn, G., Lynden Roberts, Mark Arnold, et al.. (2013). A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control. International Journal of Rheumatic Diseases. 16(5). 532–538. 17 indexed citations

Littlejohn, G., et al.. (2012). Psychological control is a key modulator of fibromyalgia symptoms and comorbidities. Journal of Pain Research. 5. 463–463. 19 indexed citations

Chappell, Amy S., G. Littlejohn, Daniel K. Kajdasz, et al.. (2009). A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia. Clinical Journal of Pain. 25(5). 365–375. 53 indexed citations

Ebringer, R., Michael Ahern, Helen R. Griffiths, et al.. (1992). Sulfasalazine in early rheumatoid arthritis. 19(11). 1672–1677. 66 indexed citations

Sellick, Ken, G. Littlejohn, Carol A. Wallace, & Ray Over. (1990). Identifying subclasses of patients with rheumatoid arthritis through cluster analysis.. PubMed. 17(12). 1613–9. 5 indexed citations

10.

Hall, Stephen, et al.. (1986). The painful swollen calf: A comparative evaluation of four investigative techniques. The Medical Journal of Australia. 144(7). 356–358. 4 indexed citations

11.

Keystone, Edward, et al.. (1982). Steady-state plasma levels of salicylate in patients with rheumatoid arthritis: effects of dosing interval and tablet strength.. PubMed. 127(4). 283–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact